Musculoskeletal Cancers Remote Monitoring and Care
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Case Comprehensive Cancer Center
- Study ID
- NCT07129226
- Status
- Recruiting
Conditions
- Metastatic Bone Disease
- Osteosarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Smart Watch — OTHERParticipants will be asked to wear the smartwatch daily, for at least 12 hours per day during the 12-week study period, with breaks to recharge the watch as needed.
Study Details
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Key Dates
- Start date
- Feb 11, 2026
- Status verified
- Jun 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Sarcoma patients
- Experimental: Palliative radiation for metastatic bone disease patients
- Experimental: prophylactic surgery for metastatic bone disease patients
Primary Outcome Measure
Adherence Rate post surgery in patients with sarcoma of the lower extremity or pelvis [ Time Frame: 3 months ]
Central Contacts
- Zachary Burke, MD216-445-9174
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Case Comprehensive Cancer Center, Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Rowan Barker-Clarke, Post-Doc Fellow (SUB_INVESTIGATOR) |
Find similar trials in Cleveland, OH
Related Studies
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruiting · Children's Oncology Group · Birmingham, Alabama
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaPHASE3 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaPHASE1/PHASE2 · Recruiting · MedPacto, Inc. · Cleveland, Ohio
- SPEARHEAD-3 Pediatric StudyPHASE1/PHASE2 · Recruiting · USWM CT, LLC · Palo Alto, California